BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 28728064)

  • 1. LDL subfractions are associated with incident cardiovascular disease in the Malmö Prevention Project Study.
    Shiffman D; Louie JZ; Caulfield MP; Nilsson PM; Devlin JJ; Melander O
    Atherosclerosis; 2017 Aug; 263():287-292. PubMed ID: 28728064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atherogenic Lipoprotein Subfractions Determined by Ion Mobility and First Cardiovascular Events After Random Allocation to High-Intensity Statin or Placebo: The Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) Trial.
    Mora S; Caulfield MP; Wohlgemuth J; Chen Z; Superko HR; Rowland CM; Glynn RJ; Ridker PM; Krauss RM
    Circulation; 2015 Dec; 132(23):2220-9. PubMed ID: 26408274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is Isolated Low High-Density Lipoprotein Cholesterol a Cardiovascular Disease Risk Factor? New Insights From the Framingham Offspring Study.
    Bartlett J; Predazzi IM; Williams SM; Bush WS; Kim Y; Havas S; Toth PP; Fazio S; Miller M
    Circ Cardiovasc Qual Outcomes; 2016 May; 9(3):206-212. PubMed ID: 27166203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advanced lipoprotein profile disturbances in type 1 diabetes mellitus: a focus on LDL particles.
    Amor AJ; Castelblanco E; Hernández M; Gimenez M; Granado-Casas M; Blanco J; Soldevila B; Esmatjes E; Conget I; Alonso N; Ortega E; Mauricio D
    Cardiovasc Diabetol; 2020 Aug; 19(1):126. PubMed ID: 32772924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ion mobility analysis of lipoprotein subfractions identifies three independent axes of cardiovascular risk.
    Musunuru K; Orho-Melander M; Caulfield MP; Li S; Salameh WA; Reitz RE; Berglund G; Hedblad B; Engström G; Williams PT; Kathiresan S; Melander O; Krauss RM
    Arterioscler Thromb Vasc Biol; 2009 Nov; 29(11):1975-80. PubMed ID: 19729614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can the Plasma Concentration Ratio of Triglyceride/High-Density Lipoprotein Cholesterol Identify Individuals at High Risk of Cardiovascular Disease During 40-Year Follow-Up?
    Lind L; Ingelsson E; Ärnlöv J; Sundström J; Zethelius B; Reaven GM
    Metab Syndr Relat Disord; 2018 Oct; 16(8):433-439. PubMed ID: 30183521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble urokinase plasminogen activator receptor in plasma is associated with incidence of CVD. Results from the Malmö Diet and Cancer Study.
    Persson M; Engström G; Björkbacka H; Hedblad B
    Atherosclerosis; 2012 Feb; 220(2):502-5. PubMed ID: 22119508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of cardiovascular disease and its associated risk factors in at-risk men and women in the United Arab Emirates: a 9-year retrospective cohort study.
    Al-Shamsi S; Regmi D; Govender RD
    BMC Cardiovasc Disord; 2019 Jun; 19(1):148. PubMed ID: 31208354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small dense low-density lipoproteins cholesterol can predict incident cardiovascular disease in an urban Japanese cohort: the Suita study.
    Arai H; Kokubo Y; Watanabe M; Sawamura T; Ito Y; Minagawa A; Okamura T; Miyamato Y
    J Atheroscler Thromb; 2013; 20(2):195-203. PubMed ID: 23076217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atherogenic Lipoprotein Determinants of Cardiovascular Disease and Residual Risk Among Individuals With Low Low-Density Lipoprotein Cholesterol.
    Lawler PR; Akinkuolie AO; Chu AY; Shah SH; Kraus WE; Craig D; Padmanabhan L; Glynn RJ; Ridker PM; Chasman DI; Mora S
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28733430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-High-Density Lipoprotein Cholesterol Levels From Childhood to Adulthood and Cardiovascular Disease Events.
    Wu F; Jacobs DR; Daniels SR; Kähönen M; Woo JG; Sinaiko AR; Viikari JSA; Bazzano LA; Steinberger J; Urbina EM; Venn AJ; Raitakari OT; Dwyer T; Juonala M; Magnussen CG
    JAMA; 2024 Jun; 331(21):1834-1844. PubMed ID: 38607340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trajectories of Blood Lipid Concentrations Over the Adult Life Course and Risk of Cardiovascular Disease and All-Cause Mortality: Observations From the Framingham Study Over 35 Years.
    Duncan MS; Vasan RS; Xanthakis V
    J Am Heart Assoc; 2019 Jun; 8(11):e011433. PubMed ID: 31137992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triglyceride-Rich Lipoprotein Cholesterol, Small Dense LDL Cholesterol, and Incident Cardiovascular Disease.
    Duran EK; Aday AW; Cook NR; Buring JE; Ridker PM; Pradhan AD
    J Am Coll Cardiol; 2020 May; 75(17):2122-2135. PubMed ID: 32354380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of a 2-year trial of nutritional ketosis on indices of cardiovascular disease risk in patients with type 2 diabetes.
    Athinarayanan SJ; Hallberg SJ; McKenzie AL; Lechner K; King S; McCarter JP; Volek JS; Phinney SD; Krauss RM
    Cardiovasc Diabetol; 2020 Dec; 19(1):208. PubMed ID: 33292205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term risk of cardiovascular events across a spectrum of adverse major plasma lipid combinations in the Framingham Heart Study.
    Andersson C; Lyass A; Vasan RS; Massaro JM; D'Agostino RB; Robins SJ
    Am Heart J; 2014 Dec; 168(6):878-83.e1. PubMed ID: 25458651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of serum concentrations of remnant cholesterol with incident cardiovascular disease in patients with rheumatoid arthritis: A real-world data from 2001 to 2022.
    Zou YW; Wu T; Li QH; Ma JD; Pan J; Lu Y; Lin JZ; Jia PW; Zheng HW; Gao JW; Dai W; Mo YQ; Dai J; Dai L
    Int J Cardiol; 2024 Jun; 405():131947. PubMed ID: 38458390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of Lipoprotein Subfractions in 920 Patients With and Without Type 2 Diabetes.
    Zhao X; Zhang HW; Zhang Y; Li S; Xu RX; Sun J; Zhu CG; Wu NQ; Gao Y; Guo YL; Liu G; Dong Q; Li JJ
    Heart Lung Circ; 2017 Mar; 26(3):211-218. PubMed ID: 28027866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and extent of dyslipidemia and recommended lipid levels in US adults with and without cardiovascular comorbidities: the National Health and Nutrition Examination Survey 2003-2004.
    Ghandehari H; Kamal-Bahl S; Wong ND
    Am Heart J; 2008 Jul; 156(1):112-9. PubMed ID: 18585505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating Branched-Chain Amino Acids and Incident Cardiovascular Disease in a Prospective Cohort of US Women.
    Tobias DK; Lawler PR; Harada PH; Demler OV; Ridker PM; Manson JE; Cheng S; Mora S
    Circ Genom Precis Med; 2018 Apr; 11(4):e002157. PubMed ID: 29572205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of electronegative low-density lipoprotein in cardiovascular diseases and its therapeutic implications.
    Akyol S; Lu J; Akyol O; Akcay F; Armutcu F; Ke LY; Chen CH
    Trends Cardiovasc Med; 2017 May; 27(4):239-246. PubMed ID: 28040327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.